报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 56.06% | -10.74% | 0.52% | 62/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
2024-12-31 | 55.77% | -10.15% | -2.96% | 66/159 | 51.8% | 首药控股 | 98.96% | 行业排名> |
2024-09-30 | 57.47% | -8.42% | -4.9% | 62/159 | 22.98% | 迪哲医药 | 97.73% | 行业排名> |
2024-06-30 | 60.43% | -1.8% | -3.79% | 52/159 | 33.39% | 百利天恒 | 97.99% | 行业排名> |
2024-03-31 | 62.81% | 2% | 1.19% | 45/159 | 51.73% | 百利天恒 | 98.92% | 行业排名> |
2023-12-31 | 62.07% | 2.56% | -1.08% | 48/159 | 51.53% | 迈威生物 | 98.93% | 行业排名> |
2023-09-30 | 62.75% | 2% | 1.97% | 46/159 | 32.76% | 迈威生物 | 99.59% | 行业排名> |
2023-06-30 | 61.54% | -9.4% | 1.68% | 55/159 | 38.65% | 迈威生物 | 99.8% | 行业排名> |
2022-12-31 | 60.52% | -7.89% | -7.89% | 57/159 | 53.74% | 迈威生物 | 99.46% | 行业排名> |
2021-12-31 | 65.71% | 2% | -3.26% | 53/159 | 55.21% | 迈威生物 | 99.75% | 行业排名> |
2021-06-30 | 67.93% | 2% | 2% | 44/159 | 47.45% | 迈威生物 | 99.67% | 行业排名> |